MAPT and Alzheimer disease: These mutations result in AD‐like pathology: by 6 months of age, Aβ pathology develops in the frontal cortex and there are elevations in pathological tau hyperphosphorylation in the hippocampus, and by 12 months of age pathology is widespread (Oddo et al. 2003; Winslow et al. 2021).